Revised CDC guidelines underscore mother's health. Centers for Disease Control and Prevention.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002487:Centers for Disease Control and Prevention, U.S.; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D017408:Guidelines as Topic; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D010347:Patient Care Planning; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D015995:Prevalence; D014481:United States / Q000453:epidemiology; D015215:Zidovudine / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D015215:Zidovudine